Citron Research

Citron Research has been publishing columns for over 17 years, making it one of the longest-running online stock commentary websites. With over 150 reports, Citron has amassed a track record identifying fraud and terminal business models second to none among any published source.

Visit Website
Citron Research Reports
Reports from 2023 - 2024
Search Report
Logo Company Name Report Date Current Price % Gain/Loss since Short reported Action
Apellis Pharmaceuticals Apellis Pharmaceuticals 06/05/2024 28.06 -0.6726% Reporter